Pulse Biosciences Inc. has announced the issuance of inducement stock options to four newly hired employees, allowing them to purchase a total of 8,300 shares of company common stock. Approved by the independent Compensation Committee, these options are in line with Nasdaq Listing Rule 5635(c)(4) and are part of the company's 2017 Inducement Equity Incentive Plan. Each option has an exercise price of $17.13 per share, matching the closing price on May 19, 2025. The options will vest over four years, with a quarter of each award vesting annually, contingent on ongoing employment with Pulse Biosciences.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。